홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-[4-(4-Amino-2-methoxy-phenyl)-piperidin-1-yl]-acetamide → Trifluoroacetic acid

HRID 1262144
인쇄

반응식

HRID 1262144 반응식
[CH3:1][O:2][C:3]1[CH:8]=[C:7]([NH:9][C:10]2[N:15]=[CH:14][C:13]3=[CH:16][CH:17]=[C:18]([C:19]4[CH:20]=[N:21][C:22]([O:25][CH3:26])=[CH:23][CH:24]=4)[N:12]3[N:11]=2)[CH:6]=[CH:5][C:4]=1[CH:27]1[CH2:32][CH2:31][N:30]([CH2:33][C:34]([NH2:36])=[O:35])[CH2:29][CH2:28]1.COC1N=CC(C2N3C(C=NC(OS([C:58]([F:61])([F:60])[F:59])(=O)=O)=N3)=CC=2)=CC=1.NC1C=CC(C2CCN(CC(N)=O)CC2)=C([O:79][CH3:80])C=1>>[CH3:1][O:2][C:3]1[CH:8]=[C:7]([NH:9][C:10]2[N:15]=[CH:14][C:13]3=[CH:16][CH:17]=[C:18]([C:19]4[CH:20]=[N:21][C:22]([O:25][CH3:26])=[CH:23][CH:24]=4)[N:12]3[N:11]=2)[CH:6]=[CH:5][C:4]=1[CH:27]1[CH2:32][CH2:31][N:30]([CH2:33][C:34]([NH2:36])=[O:35])[CH2:29][CH2:28]1.[C:80]([OH:79])([C:58]([F:59])([F:60])[F:61])=[O:2]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 667119832-[4-(4-Amino-2-methoxy-phenyl)-piperidin-1-yl]-acetamideHCID 667123102-(4-{2-Methoxy-4-[7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-phenyl}-piperidin-1-yl)-acetamideHCID 86661684Trifluoro-methanesulfonic acid 7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-yl ester

생성물 2

HCID 6422Trifluoroacetic acid수율 33%
HCID 66712310
2-(4-{2-Methoxy-4-[7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-phenyl}-piperidin-1-yl)-acetamide

실험 절차

2-(4-{2-Methoxy-4-[7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-ylamino]-phenyl}-piperidin-1-yl)-acetamide. Trifluoro-methanesulfonic acid 7-(6-methoxy-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-yl ester (0.138 g, 0.369 mmol; and 2-[4-(4-Amino-2-methoxy-phenyl)-piperidin-1-yl]-acetamide (0.121 g, 0.461 mmol) were reacted in an analogous manner to Example 908D at room temp for 72 h. The reaction mixture was concentrated, taken up in EtOAc, and washed with brine. The EtOAc layer was dried, filtered over MgSO4, and concentrated. The resulting residue was purified by Gilson RP-HPLC and lyophilized to afford title compound as a TFA salt (59 mg, 33%). LCMS=488.0 (M+H), HPLC rt=2.329, purity=99%. 1H NMR (400 MHz, (D3C)2SO, δ, ppm): 9.53 (bs, 1H), 9.47 (s, 1H), 9.02 (s, 1H), 9.00 (d, J=8.2 Hz, 1H), 8.40 (dd, J=8.7 Hz, 2.3 Hz, 1H), 7.98 (s, 1H), 7.71 (s, 1H), 7.46 (s, 1H), 7.24 (d, J=8.5 Hz, 1H), 7.17 (d, J=4.9 Hz, 1H), 7.04 (d, J=8.3 Hz, 1H0, 6.97 (d, J=4.7 Hz, 1H), 6.93 (s, 1H), 3.93 (s, 3H), 3.89 (m, 2H), 3.70 (s, 3H), 3.54 (d, J=11.7 Hz, 2H), 3.23-3.05 (m, 3H), 2.05-1.95 (m, 2H), 1.85-1.88 (m, 2H).

후처리

  1. concentrationThe reaction mixture was concentrated
  2. washwashed with brine
  3. dry with materialThe EtOAc layer was dried
  4. filtrationfiltered over MgSO4
  5. concentrationconcentrated
  6. customThe resulting residue was purified by Gilson RP-HPLC

출처 및 근거

ORD 기록
ord-372c9a3157264ba8a23d92f08edb7e4c
출처 데이터셋
uspto-grants-2013_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08471005B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트